Ziba Rajaei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ziba Rajaei has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Hojjatallah Alaei
Department of physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
6 shared publicationsMousa-Al-Reza Hadjzadeh
Department of Physiology, School of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran
4 shared publicationsAbolfazl Khajavi Rad
2 shared publicationsHossein Salehi
Isfahan University of Medical Sciences
2 shared publications- Hossein Salehi
Department of Anatomical Sciences and Reproductive Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 shared publications - Maryam Dastan
Department of physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 shared publications
Latest Publications
- 25 April 2025
- Published by Springer Nature in Neurological Sciences
- Vol. 46  (8) , 3783-3795
The association between information processing speed and clinical features in people with multiple sclerosis and neuromyelitis optica: a comparative study
Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) are both autoimmune inflammatory disorders affecting the central nervous system. Cognitive decline is a common symptom in both disorders, particularly affecting information processing speed (IPS). The current study investigated the association between IPS and clinical parameters in people with MS (PwMS) and NMOSD (PwNMOSD). A total of 945 participants were enrolled in the study, including 617 PwMS, 128 PwNMOSD, and 200 healthy controls. IPS was evaluated using the Symbol Digit Modalities Test (SDMT). Clinical, serological, and radiological factors were retrospectively collected. General Linear Model (GLM) was used for data analysis. Based on GLM multivariate analysis adjusted for age, sex, and educational level, a significant association was observed between IPS and Expanded Disability Status Scale (EDSS), disease progression, disease duration, brain atrophy, and brain lesion load in PwMS. Similarly, significant association was found between IPS and EDSS, Aquaporin-4 (AQP-4) antibody positivity, brain atrophy, and number of cervical lesions in PwNMOSD. This study confirms the association between IPS and key risk factors such as EDSS, brain atrophy, and lesion load in PwMS. Additionally, it reveals a link between IPS and new factors, including AQP-4 antibody positivity and cervical lesions in PwNMOSD. Furthermore, disease progression emerged as a significant factor affecting IPS in PwMS.
- 25 April 2025
- Published by Springer Nature in Neurological Sciences
- Vol. 46  (8) , 3783-3795
The association between information processing speed and clinical features in people with multiple sclerosis and neuromyelitis optica: a comparative study
Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) are both autoimmune inflammatory disorders affecting the central nervous system. Cognitive decline is a common symptom in both disorders, particularly affecting information processing speed (IPS). The current study investigated the association between IPS and clinical parameters in people with MS (PwMS) and NMOSD (PwNMOSD). A total of 945 participants were enrolled in the study, including 617 PwMS, 128 PwNMOSD, and 200 healthy controls. IPS was evaluated using the Symbol Digit Modalities Test (SDMT). Clinical, serological, and radiological factors were retrospectively collected. General Linear Model (GLM) was used for data analysis. Based on GLM multivariate analysis adjusted for age, sex, and educational level, a significant association was observed between IPS and Expanded Disability Status Scale (EDSS), disease progression, disease duration, brain atrophy, and brain lesion load in PwMS. Similarly, significant association was found between IPS and EDSS, Aquaporin-4 (AQP-4) antibody positivity, brain atrophy, and number of cervical lesions in PwNMOSD. This study confirms the association between IPS and key risk factors such as EDSS, brain atrophy, and lesion load in PwMS. Additionally, it reveals a link between IPS and new factors, including AQP-4 antibody positivity and cervical lesions in PwNMOSD. Furthermore, disease progression emerged as a significant factor affecting IPS in PwMS.
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14  (1) , 34
Prevalence and Odds of Cognitive Impairment in Multiple Sclerosis Subtypes and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study
Background: Autoimmune demyelinating disorders, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), are caused by persistent inflammation and damage to the central nervous system. Cognitive impairment (CI) is a growing challenge in these diseases, underscoring the need for a thorough exploration of its prevalence and risk across various subtypes. This study aimed to assess the prevalence and odds of CI using the Symbol Digit Modalities Test (SDMT) in various MS subtypes and NMOSD. Materials and Methods: A case–control study involving 616 participants, including healthy controls (HC) and individuals with different MS subtypes (Relapsing Remitting MS (RRMS), Secondary Progressive MS (SPMS), Primary Progressive MS (PPMS)), clinically isolated syndrome (CIS), and NMOSD, was conducted. CI was defined as SDMT z-scores 1.5 standard deviations below the HC average. The chi-square test was used to assess the risk of CI. Results: The prevalence of CI varied across different groups: HC (10.7%), RRMS (33.8%), SPMS (71.3%), PPMS (62.8%), CIS (19.2%), and NMOSD (32.8%). Odds ratios (OR) for CI were significantly increased in RRMS (OR: 4.23, confidence interval (CI): 2.18-8.22, P < 0.001), SPMS (OR: 20.58, CI: 10.36-40.88, P < 0.001), PPMS (OR: 14.02, CI: 5.80-33.86, P < 0.001), and NMOSD (OR: 4.04, CI: 2.07-7.87, P < 0.001) compared to HC. Conclusion: This study emphasizes a significantly increased risk of CI in MS subtypes and NMOSD compared to HC. Although no significant difference in CI risk was found between individuals with RRMS and NMOSD, those with progressive forms of MS exhibited notably higher risks of CI.
- 1 April 2025
- Published by Wolters Kluwer Health in Advanced Biomedical Research
- Vol. 14  (1) , 34
Open AccessPrevalence and Odds of Cognitive Impairment in Multiple Sclerosis Subtypes and Neuromyelitis Optica Spectrum Disorder: A Case–Control Study
Background: Autoimmune demyelinating disorders, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), are caused by persistent inflammation and damage to the central nervous system. Cognitive impairment (CI) is a growing challenge in these diseases, underscoring the need for a thorough exploration of its prevalence and risk across various subtypes. This study aimed to assess the prevalence and odds of CI using the Symbol Digit Modalities Test (SDMT) in various MS subtypes and NMOSD. Materials and Methods: A case–control study involving 616 participants, including healthy controls (HC) and individuals with different MS subtypes (Relapsing Remitting MS (RRMS), Secondary Progressive MS (SPMS), Primary Progressive MS (PPMS)), clinically isolated syndrome (CIS), and NMOSD, was conducted. CI was defined as SDMT z-scores 1.5 standard deviations below the HC average. The chi-square test was used to assess the risk of CI. Results: The prevalence of CI varied across different groups: HC (10.7%), RRMS (33.8%), SPMS (71.3%), PPMS (62.8%), CIS (19.2%), and NMOSD (32.8%). Odds ratios (OR) for CI were significantly increased in RRMS (OR: 4.23, confidence interval (CI): 2.18-8.22, P < 0.001), SPMS (OR: 20.58, CI: 10.36-40.88, P < 0.001), PPMS (OR: 14.02, CI: 5.80-33.86, P < 0.001), and NMOSD (OR: 4.04, CI: 2.07-7.87, P < 0.001) compared to HC. Conclusion: This study emphasizes a significantly increased risk of CI in MS subtypes and NMOSD compared to HC. Although no significant difference in CI risk was found between individuals with RRMS and NMOSD, those with progressive forms of MS exhibited notably higher risks of CI.
- 4 December 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62  (5) , 5804-5815
Crocin Improves Cognitive Impairment in LPS-treated Rats through Anti-Apoptotic, Anti-Inflammatory, and Antioxidant Activities
Brain inflammation and oxidative stress play critical roles in neuronal apoptosis and memory dysfunction in Alzheimer’s disease. Crocin, a natural carotenoid in the stigma of saffron, possesses radical scavenging, anti-inflammatory, and anti-apoptotic properties. This study investigates the protective impact of crocin on neuronal apoptosis, oxidative stress, neuroinflammation, and memory deficits induced by lipopolysaccharide (LPS) in rats. Male Wistar rats received 100 mg/kg of crocin for 12 days, with LPS (1 mg/kg, ip) injected on days 8–12. Spatial learning and memory were evaluated in the Morris water maze two hours after LPS injection. Gene expression of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α), caspase 3, and lipid peroxidation was assessed in hippocampal homogenates at the end of the behavioral test. Histopathological changes in the hippocampus and cerebral cortex were evaluated using H&E staining. The results indicated that LPS administration caused spatial learning and memory dysfunction (P = 0.001, P < 0.01) accompanied by upregulation of Nfkb, Tnfα, and Casp3 mRNA expression (P < 0.0001), increased TNF-α (P < 0.01) and lipid peroxidation level (P < 0.01), decreased total thiol concentration (P < 0.05), tissue damage and neuronal loss in the hippocampus (P < 0.0001). Furthermore, crocin treatment at a dosage of 100 mg/kg attenuated learning and memory impairments (P = 0.001, P < 0.01), downregulated Nfkb, Tnfα, and Casp3 mRNA expression (P < 0.0001), decreased TNF-α level (P < 0.01) and lipid peroxidation (P < 0.05) and increased total thiol level (P < 0.05) in the hippocampus. Crocin also ameliorated LPS-induced pathological changes and neuronal loss in the hippocampus (P < 0.001) and cerebral cortex (P < 0.01). In conclusion, the neuroprotective effects of crocin against LPS-induced histopathological and behavioral changes could be attributed to its anti-apoptotic, anti-inflammatory, and radical-scavenging activities in the rat brain.
- 4 December 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62  (5) , 5804-5815
Crocin Improves Cognitive Impairment in LPS-treated Rats through Anti-Apoptotic, Anti-Inflammatory, and Antioxidant Activities
Brain inflammation and oxidative stress play critical roles in neuronal apoptosis and memory dysfunction in Alzheimer’s disease. Crocin, a natural carotenoid in the stigma of saffron, possesses radical scavenging, anti-inflammatory, and anti-apoptotic properties. This study investigates the protective impact of crocin on neuronal apoptosis, oxidative stress, neuroinflammation, and memory deficits induced by lipopolysaccharide (LPS) in rats. Male Wistar rats received 100 mg/kg of crocin for 12 days, with LPS (1 mg/kg, ip) injected on days 8–12. Spatial learning and memory were evaluated in the Morris water maze two hours after LPS injection. Gene expression of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α), caspase 3, and lipid peroxidation was assessed in hippocampal homogenates at the end of the behavioral test. Histopathological changes in the hippocampus and cerebral cortex were evaluated using H&E staining. The results indicated that LPS administration caused spatial learning and memory dysfunction (P = 0.001, P < 0.01) accompanied by upregulation of Nfkb, Tnfα, and Casp3 mRNA expression (P < 0.0001), increased TNF-α (P < 0.01) and lipid peroxidation level (P < 0.01), decreased total thiol concentration (P < 0.05), tissue damage and neuronal loss in the hippocampus (P < 0.0001). Furthermore, crocin treatment at a dosage of 100 mg/kg attenuated learning and memory impairments (P = 0.001, P < 0.01), downregulated Nfkb, Tnfα, and Casp3 mRNA expression (P < 0.0001), decreased TNF-α level (P < 0.01) and lipid peroxidation (P < 0.05) and increased total thiol level (P < 0.05) in the hippocampus. Crocin also ameliorated LPS-induced pathological changes and neuronal loss in the hippocampus (P < 0.001) and cerebral cortex (P < 0.01). In conclusion, the neuroprotective effects of crocin against LPS-induced histopathological and behavioral changes could be attributed to its anti-apoptotic, anti-inflammatory, and radical-scavenging activities in the rat brain.
- 18 November 2024
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40  (1) , 1-11
Gallic acid ameliorates LPS-induced memory decline by modulating NF-κB, TNF-α, and Caspase 3 gene expression and attenuating oxidative stress and neuronal loss in the rat hippocampus
Neuroinflammation and apoptosis play critical roles in the pathogenesis of Alzheimer’s disease (AD), which is responsible for most cases of dementia in the elderly people. Gallic acid is a phenolic compound with radical scavenging, anti-inflammatory and anti-apoptotic activities. This study aimed to explore the protective effects of gallic acid on LPS-induced spatial memory impairment and find the underlying mechanisms. Gallic acid was orally administered (100 mg/kg) to male Wistar rats for 12 days. LPS was injected intraperitoneally at a dose of 1 mg/kg on days 8–12. Morris water maze paradigm was used to evaluate spatial learning and memory. The mRNA level of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α) and Caspase 3, lipid peroxidation and total thiol level was assessed in the rat hippocampus. Neuronal loss and histological changes were also evaluated in the brain. LPS treatment resulted in spatial learning and memory impairment, upregulation of NF-κB, TNF-α, and Caspase 3 mRNA expression, increased lipid peroxidation, decreased total thiol level, and neuronal loss in the hippocampus. Moreover, treatment with gallic acid at a dosage of 100 mg/kg ameliorated memory decline, reduced the mRNA level of NF-κB, TNF-α, and Caspase 3, decreased lipid peroxidation and increased total thiol level in the hippocampus. Gallic acid also prevented LPS-induced neuronal loss and histological changes in the brain. Conclusively, our study demonstrated that gallic acid exerts neuroprotective effect against LPS-induced memory decline in rats. This outcome could be due to anti-inflammatory, antioxidant, and anti-apoptotic activities of gallic acid.
- 18 November 2024
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40  (1) , 1-11
Gallic acid ameliorates LPS-induced memory decline by modulating NF-κB, TNF-α, and Caspase 3 gene expression and attenuating oxidative stress and neuronal loss in the rat hippocampus
Neuroinflammation and apoptosis play critical roles in the pathogenesis of Alzheimer’s disease (AD), which is responsible for most cases of dementia in the elderly people. Gallic acid is a phenolic compound with radical scavenging, anti-inflammatory and anti-apoptotic activities. This study aimed to explore the protective effects of gallic acid on LPS-induced spatial memory impairment and find the underlying mechanisms. Gallic acid was orally administered (100 mg/kg) to male Wistar rats for 12 days. LPS was injected intraperitoneally at a dose of 1 mg/kg on days 8–12. Morris water maze paradigm was used to evaluate spatial learning and memory. The mRNA level of nuclear factor kappa B (NF-κB), tumor necrosis factor-α (TNF-α) and Caspase 3, lipid peroxidation and total thiol level was assessed in the rat hippocampus. Neuronal loss and histological changes were also evaluated in the brain. LPS treatment resulted in spatial learning and memory impairment, upregulation of NF-κB, TNF-α, and Caspase 3 mRNA expression, increased lipid peroxidation, decreased total thiol level, and neuronal loss in the hippocampus. Moreover, treatment with gallic acid at a dosage of 100 mg/kg ameliorated memory decline, reduced the mRNA level of NF-κB, TNF-α, and Caspase 3, decreased lipid peroxidation and increased total thiol level in the hippocampus. Gallic acid also prevented LPS-induced neuronal loss and histological changes in the brain. Conclusively, our study demonstrated that gallic acid exerts neuroprotective effect against LPS-induced memory decline in rats. This outcome could be due to anti-inflammatory, antioxidant, and anti-apoptotic activities of gallic acid.
- Open Access
- 8 February 2024
- Published by Springer Nature in Research Square
Crocin improves cognitive impairment in LPS-treated rats by anti-apoptotic, anti-inflammatory and antioxidant activities
Brain inflammation and oxidative stress play a critical role in the neuronal apoptosis and memory dysfunction in Alzheimer’s disease. Crocin is a natural carotenoid present in the stigma of saffron which possesses radical scavenging, anti-inflammatory, and anti-apoptotic properties. The present study examined the protective impact of crocin on neuronal apoptosis, oxidative stress, neuroinflammation and memory deficits induced by lipopolysaccharide (LPS) in rats. Wistar rats received crocin at a dose of 100 mg/kg for 12 days. Besides, LPS (1 mg/kg, ip) was injected on days 8–12. Spatial memory was evaluated in the Morris water maze, two hours after LPS injection on days 8–12. Gene expression of nuclear factor (NF)-κB, tumor necrosis factor-α (TNF-α), caspase 3 and lipid peroxidation was assessed in the hippocampal homogenates at the end of behavioral test. Histopathological changes in the hippocampus and cerebral cortex was evaluated using H&E staining. According to results, administration of LPS caused spatial memory dysfunction accompanied by upregulation of mRNA expression of NF-κB, TNF-α and caspase 3 as well as increased lipid peroxidation and tissue damge in the hippocampus. Furthermore, crocin treatment at a dose of 100 mg/kg attenuated memory impairments, downregulated the mRNA expression of NF-κB, TNF-α and caspase 3 and decreased lipid peroxidation in the hippocampus. Crocin also ameliorated LPS-induced pathological changes and neuronal loss in the hippocampus and cerebral cortex. In conclusion, neuroprotective effects of crocin against LPS-induced histopathological and behavioural changes could be attributed to its anti-apoptotic, anti-inflammatory and radical-scavenging activities in the rat brain.
- 8 February 2024
- Published by Springer Nature in Research Square
Open AccessCrocin improves cognitive impairment in LPS-treated rats by anti-apoptotic, anti-inflammatory and antioxidant activities
Brain inflammation and oxidative stress play a critical role in the neuronal apoptosis and memory dysfunction in Alzheimer’s disease. Crocin is a natural carotenoid present in the stigma of saffron which possesses radical scavenging, anti-inflammatory, and anti-apoptotic properties. The present study examined the protective impact of crocin on neuronal apoptosis, oxidative stress, neuroinflammation and memory deficits induced by lipopolysaccharide (LPS) in rats. Wistar rats received crocin at a dose of 100 mg/kg for 12 days. Besides, LPS (1 mg/kg, ip) was injected on days 8–12. Spatial memory was evaluated in the Morris water maze, two hours after LPS injection on days 8–12. Gene expression of nuclear factor (NF)-κB, tumor necrosis factor-α (TNF-α), caspase 3 and lipid peroxidation was assessed in the hippocampal homogenates at the end of behavioral test. Histopathological changes in the hippocampus and cerebral cortex was evaluated using H&E staining. According to results, administration of LPS caused spatial memory dysfunction accompanied by upregulation of mRNA expression of NF-κB, TNF-α and caspase 3 as well as increased lipid peroxidation and tissue damge in the hippocampus. Furthermore, crocin treatment at a dose of 100 mg/kg attenuated memory impairments, downregulated the mRNA expression of NF-κB, TNF-α and caspase 3 and decreased lipid peroxidation in the hippocampus. Crocin also ameliorated LPS-induced pathological changes and neuronal loss in the hippocampus and cerebral cortex. In conclusion, neuroprotective effects of crocin against LPS-induced histopathological and behavioural changes could be attributed to its anti-apoptotic, anti-inflammatory and radical-scavenging activities in the rat brain.
- 29 January 2024
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 21  (2) , 191-196
Effects of Berberis vulgaris fruit extract on oxidative stress status in the kidney and liver of diabetic rats
Objectives: Oxidative stress has a key role in the diabetes pathogenesis and complications. Berberis vulgaris is known in folk medicine for curing several diseases. The current research aimed to assess the influences of Berberis vulgaris fruit extract against oxidative stress in streptozotocin-induced diabetic rats. Methods: Streptozotocin (60 mg/kg, ip) was injected to male rats. After diabetes confirmation, animals received the Berberis vulgaris fruit extract daily at amounts of 3.5 and 7.5 % of drinking water (v/v) for six weeks. Total thiol and lipid peroxidation levels were assessed in the serum, liver, kidney and spleen at the end of the study. Results: Diabetic rats exhibited hyperglycemia along with enhancement of lipid peroxidation levels in the serum, liver, kidney and spleen, and decrement of total thiol content in the kidney and liver tissues. Chronic administration of Berberis vulgaris fruit extract at amount of 3.5 % of drinking water decreased the lipid peroxidation level in the serum and liver, and enhanced total thiol level in the liver and kidney. Conclusions: Berberis vulgaris fruit extract exerts antioxidant activity in the serum, liver and kidney organs of diabetic rats. Therefore, it might be used in the prevention and control of diabetes complications.
- 29 January 2024
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 21  (2) , 191-196
Effects of Berberis vulgaris fruit extract on oxidative stress status in the kidney and liver of diabetic rats
Objectives: Oxidative stress has a key role in the diabetes pathogenesis and complications. Berberis vulgaris is known in folk medicine for curing several diseases. The current research aimed to assess the influences of Berberis vulgaris fruit extract against oxidative stress in streptozotocin-induced diabetic rats. Methods: Streptozotocin (60 mg/kg, ip) was injected to male rats. After diabetes confirmation, animals received the Berberis vulgaris fruit extract daily at amounts of 3.5 and 7.5 % of drinking water (v/v) for six weeks. Total thiol and lipid peroxidation levels were assessed in the serum, liver, kidney and spleen at the end of the study. Results: Diabetic rats exhibited hyperglycemia along with enhancement of lipid peroxidation levels in the serum, liver, kidney and spleen, and decrement of total thiol content in the kidney and liver tissues. Chronic administration of Berberis vulgaris fruit extract at amount of 3.5 % of drinking water decreased the lipid peroxidation level in the serum and liver, and enhanced total thiol level in the liver and kidney. Conclusions: Berberis vulgaris fruit extract exerts antioxidant activity in the serum, liver and kidney organs of diabetic rats. Therefore, it might be used in the prevention and control of diabetes complications.
- 1 March 2023
- Vol. 13  (2) , 213-222
Neuroprotective effects of sesamol against LPS-induced spatial learning and memory deficits are mediated via anti-inflammatory and antioxidant activities in the rat brain
Objective: Sesamol is a phenolic lignan extracted from sesame seeds, and it possesses anti-inflammatory and antioxidant activities. Lipopolysaccharide (LPS) is known to produce neuroinflammatory responses and memory impairment. The current study aimed to investigate the protective influence of sesamol against LPS-mediated neuroinflammation and memory impairment.Materials and Methods: Sesamol (10 and 50 mg/kg) was injected to Wistar rats for two weeks. Then, animals received LPS injection (1 mg/kg) for five days, while treatment with sesamol was performed 30 min before LPS injection. Spatial learning and memory were assessed by the Morris water maze (MWM), two hours after LPS injection on days 15-19. Biochemical assessments were performed after the end of behavioral experiments.Results: LPS-administered rats showed spatial learning and memory deficits, since they spent more time in the MWM to find the hidden platform and less time in the target quadrant. Besides these behavioral changes, tumor necrosis factor-alpha (TNF-alpha) and lipid peroxidation levels were increased, while total thiol level was decreased in the hippocampus and/or cerebral cortex. In addition, sesamol treatment (50 mg/kg) for three weeks decreased the escape latency and increased the time on probe trial. Sesamol also reduced lipid peroxidation and TNF-alpha level, while enhanced total thiol level in the brain of LPS-exposed rats.Conclusion: Supplementation of sesamol attenuated learning and memory impairments in LPS-treated rats via antioxidative and anti-inflammatory activities in the rat brain.
- 1 March 2023
- Vol. 13  (2) , 213-222
Neuroprotective effects of sesamol against LPS-induced spatial learning and memory deficits are mediated via anti-inflammatory and antioxidant activities in the rat brain
Objective: Sesamol is a phenolic lignan extracted from sesame seeds, and it possesses anti-inflammatory and antioxidant activities. Lipopolysaccharide (LPS) is known to produce neuroinflammatory responses and memory impairment. The current study aimed to investigate the protective influence of sesamol against LPS-mediated neuroinflammation and memory impairment.Materials and Methods: Sesamol (10 and 50 mg/kg) was injected to Wistar rats for two weeks. Then, animals received LPS injection (1 mg/kg) for five days, while treatment with sesamol was performed 30 min before LPS injection. Spatial learning and memory were assessed by the Morris water maze (MWM), two hours after LPS injection on days 15-19. Biochemical assessments were performed after the end of behavioral experiments.Results: LPS-administered rats showed spatial learning and memory deficits, since they spent more time in the MWM to find the hidden platform and less time in the target quadrant. Besides these behavioral changes, tumor necrosis factor-alpha (TNF-alpha) and lipid peroxidation levels were increased, while total thiol level was decreased in the hippocampus and/or cerebral cortex. In addition, sesamol treatment (50 mg/kg) for three weeks decreased the escape latency and increased the time on probe trial. Sesamol also reduced lipid peroxidation and TNF-alpha level, while enhanced total thiol level in the brain of LPS-exposed rats.Conclusion: Supplementation of sesamol attenuated learning and memory impairments in LPS-treated rats via antioxidative and anti-inflammatory activities in the rat brain.
- 8 December 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38  (3) , 999-1011
Treadmill running and Levisticum Officinale extract protect against LPS-induced memory deficits by modulating neurogenesis, neuroinflammation and oxidative stress
Neuroinflammation plays an essential role in the pathogenesis of Alzheimer’s disease. The preventive effect of physical exercise on attenuating neuroinflammation has not been completely defined. Levisticum officinale is known as a medicinal plant with antioxidant and anti-inflammatory properties. The current study was designed to investigate the neuroprotective impacts of treadmill running and Levisticum officinale on lipopolysaccharide (LPS)-induced learning and memory impairments and neuroinflammation in rats. Male Wistar rats ran on a treadmill and/or were pretreated with Levisticum officinale extract at a dose of 100 mg/kg for a week. Then, rats received intraperitoneal injection of LPS at a dose of 1 mg/kg. Treadmill running and/or treatment of extract lasted three more weeks. Behavioral, molecular, biochemical and immunohistochemical assessments were carried out after the end of the experiment. LPS administration resulted in spatial learning and memory impairments along with increased mRNA expression of interleukin-6 and malondialdehyde levels, as well as decreased superoxide dismutase activity and neurogenesis in the hippocampus. Moreover, treadmill running for four weeks, alone and in combination with Levisticum officinale extract attenuated spatial learning and memory deficits, decreased the mRNA expression of interleukin-6 and malondialdehyde levels, and enhanced superoxide dismutase activity and neurogenesis in the hippocampus. In conclusion, the advantageous effects of running exercise and Levisticum officinale extract on LPS-induced memory impairments are possibly due to the antioxidant and anti-inflammatory activity and enhancing neurogenesis.
- 8 December 2022
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38  (3) , 999-1011
Treadmill running and Levisticum Officinale extract protect against LPS-induced memory deficits by modulating neurogenesis, neuroinflammation and oxidative stress
Neuroinflammation plays an essential role in the pathogenesis of Alzheimer’s disease. The preventive effect of physical exercise on attenuating neuroinflammation has not been completely defined. Levisticum officinale is known as a medicinal plant with antioxidant and anti-inflammatory properties. The current study was designed to investigate the neuroprotective impacts of treadmill running and Levisticum officinale on lipopolysaccharide (LPS)-induced learning and memory impairments and neuroinflammation in rats. Male Wistar rats ran on a treadmill and/or were pretreated with Levisticum officinale extract at a dose of 100 mg/kg for a week. Then, rats received intraperitoneal injection of LPS at a dose of 1 mg/kg. Treadmill running and/or treatment of extract lasted three more weeks. Behavioral, molecular, biochemical and immunohistochemical assessments were carried out after the end of the experiment. LPS administration resulted in spatial learning and memory impairments along with increased mRNA expression of interleukin-6 and malondialdehyde levels, as well as decreased superoxide dismutase activity and neurogenesis in the hippocampus. Moreover, treadmill running for four weeks, alone and in combination with Levisticum officinale extract attenuated spatial learning and memory deficits, decreased the mRNA expression of interleukin-6 and malondialdehyde levels, and enhanced superoxide dismutase activity and neurogenesis in the hippocampus. In conclusion, the advantageous effects of running exercise and Levisticum officinale extract on LPS-induced memory impairments are possibly due to the antioxidant and anti-inflammatory activity and enhancing neurogenesis.
- Open Access
- 1 January 2022
- Published by Medknow in Advanced Biomedical Research
- Vol. 11  (1) , 33
Supplementation of Carvacrol Attenuates Hippocampal Tumor Necrosis Factor-Alpha Level, Oxidative Stress, and Learning and Memory Dysfunction in Lipopolysaccharide-Exposed Rats
Background: Carvacrol is a natural phenolic monoterpene with anti-inflammatory and antioxidant bioactivities. Neuroinflammatory and oxidative stress responses play a crucial role in the pathogenesis of Alzheimer's disease. The present study examined the effect of carvacrol on brain tumor necrosis factor-alpha (TNF-α) level and oxidative stress as well as spatial learning and memory performances in lipopolysaccharide (LPS)-exposed rats. Materials and Methods: The rats were treated with either carvacrol (25 and 50 mg/kg) or Tween 80 for 2 weeks. Thereafter, LPS (1 mg/kg) or saline was intraperitoneally administered on days 15–19, 2 h before Morris water maze task, and treatments with carvacrol or Tween 80 were performed 30 min prior to behavioral testing. The level of TNF-α, lipid peroxidation, and total thiol concentration were measured in the hippocampus and cerebral cortex at the end of the experiment. Results: It was found that LPS-exposed rats exhibited spatial learning and memory dysfunction, which was accompanied by increased TNF-α level and lipid peroxidation, and decreased total thiol concentration in the hippocampus and/or cortex. Moreover, treatment with carvacrol at a dose of 25 mg/kg attenuated learning and memory impairments, decreased TNF-α and lipid peroxidation level in the hippocampus and cortex, and increased total thiol concentration in the cortex. Conclusion: Carvacrol exerts neuroprotective effects against LPS-induced spatial memory deficits through attenuating hippocampal TNF-α level and oxidative stress in rats.
- 1 January 2022
- Published by Medknow in Advanced Biomedical Research
- Vol. 11  (1) , 33
Open AccessSupplementation of Carvacrol Attenuates Hippocampal Tumor Necrosis Factor-Alpha Level, Oxidative Stress, and Learning and Memory Dysfunction in Lipopolysaccharide-Exposed Rats
Background: Carvacrol is a natural phenolic monoterpene with anti-inflammatory and antioxidant bioactivities. Neuroinflammatory and oxidative stress responses play a crucial role in the pathogenesis of Alzheimer's disease. The present study examined the effect of carvacrol on brain tumor necrosis factor-alpha (TNF-α) level and oxidative stress as well as spatial learning and memory performances in lipopolysaccharide (LPS)-exposed rats. Materials and Methods: The rats were treated with either carvacrol (25 and 50 mg/kg) or Tween 80 for 2 weeks. Thereafter, LPS (1 mg/kg) or saline was intraperitoneally administered on days 15–19, 2 h before Morris water maze task, and treatments with carvacrol or Tween 80 were performed 30 min prior to behavioral testing. The level of TNF-α, lipid peroxidation, and total thiol concentration were measured in the hippocampus and cerebral cortex at the end of the experiment. Results: It was found that LPS-exposed rats exhibited spatial learning and memory dysfunction, which was accompanied by increased TNF-α level and lipid peroxidation, and decreased total thiol concentration in the hippocampus and/or cortex. Moreover, treatment with carvacrol at a dose of 25 mg/kg attenuated learning and memory impairments, decreased TNF-α and lipid peroxidation level in the hippocampus and cortex, and increased total thiol concentration in the cortex. Conclusion: Carvacrol exerts neuroprotective effects against LPS-induced spatial memory deficits through attenuating hippocampal TNF-α level and oxidative stress in rats.
- Open Access
- 1 January 2021
- Vol. 11  (1) , 79-90
Effects of crocin on spatial or aversive learning and memory impairments induced by lipopolysaccharide in rats
Objective: Neuroinflammation and oxidative stress play essential roles in the pathogenesis and progression of neurodegenerative diseases, such as Alzheimer's disease. Crocin, main active constituent of Crocus sativus L. (saffron), possesses antiinflammatory, anti-apoptotic and anti-oxidative capacity. The aim of the present study was to investigate the neuroprotective effect of crocin on lipopolysaccharide (LPS)-induced learning and memory deficits and neuroinflammation in rats. Materials and Methods: The animals were randomly classified into four groups, including control, LPS, crocin 50 and crocin 100. The rats were treated with either crocin (50 and 100 mg/kg) or saline for a week. Later, LPS (1 mg/kg, i.p.) or saline was administered, and treatments with crocin or saline were continued for 3 more weeks. The behavioral tasks for spatial and aversive memories were performed by the Morris water maze and passive avoidance tasks from post-injection days 18 to 24. Furthermore, the levels of interleukine-1 beta, lipid peroxidation and total thiol were assayed in the hippocampus and cerebral cortex. Results: Our results demonstrated that treatment of LPS-treated rats with crocin decreased the escape latency in the Morris water maze and increased the time spent in the target quadrant in the probe trial. Moreover, crocin increased step-through latency in the passive avoidance test. However, there was no significant difference in the oxidative and neuroinflammatory responses among the experimental groups. Conclusion: Pretreatment with crocin attenuates spatial or aversive learning and memory deficits in LPS-treated rats.
- 1 January 2021
- Vol. 11  (1) , 79-90
Open AccessEffects of crocin on spatial or aversive learning and memory impairments induced by lipopolysaccharide in rats
Objective: Neuroinflammation and oxidative stress play essential roles in the pathogenesis and progression of neurodegenerative diseases, such as Alzheimer's disease. Crocin, main active constituent of Crocus sativus L. (saffron), possesses antiinflammatory, anti-apoptotic and anti-oxidative capacity. The aim of the present study was to investigate the neuroprotective effect of crocin on lipopolysaccharide (LPS)-induced learning and memory deficits and neuroinflammation in rats. Materials and Methods: The animals were randomly classified into four groups, including control, LPS, crocin 50 and crocin 100. The rats were treated with either crocin (50 and 100 mg/kg) or saline for a week. Later, LPS (1 mg/kg, i.p.) or saline was administered, and treatments with crocin or saline were continued for 3 more weeks. The behavioral tasks for spatial and aversive memories were performed by the Morris water maze and passive avoidance tasks from post-injection days 18 to 24. Furthermore, the levels of interleukine-1 beta, lipid peroxidation and total thiol were assayed in the hippocampus and cerebral cortex. Results: Our results demonstrated that treatment of LPS-treated rats with crocin decreased the escape latency in the Morris water maze and increased the time spent in the target quadrant in the probe trial. Moreover, crocin increased step-through latency in the passive avoidance test. However, there was no significant difference in the oxidative and neuroinflammatory responses among the experimental groups. Conclusion: Pretreatment with crocin attenuates spatial or aversive learning and memory deficits in LPS-treated rats.